文献速递冠心病血脂与心血管预防

年轻成人急性心肌梗死后的新诊断糖尿病与结局

Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults.
PubMed 文献 · Heart · 2020-10-20

本研究基于VIRGO研究3501例18-55岁急性心肌梗死患者,14.5%符合新诊断糖尿病标准。新诊断糖尿病在非白人、肥胖及经济压力大的患者中更常见,且与已诊断糖尿病相比,其疾病特异性健康状况和生活质量更好,但短期死亡率和并发症无显著差异。

要点

  • 年轻AMI患者中新诊断糖尿病常见,占14.5%。
  • 新诊断糖尿病多见于非白人、肥胖及经济压力大者。
  • 新诊断糖尿病短期健康状态不劣于已诊断糖尿病。

核心结论

  • 在≤55岁急性心肌梗死患者中,新诊断糖尿病常见,且在非白人、肥胖和经济压力大的个体中更频繁。
  • 新诊断糖尿病患者中不到20%在出院时获得诊断或开始糖尿病教育或药物治疗。
  • 与已诊断糖尿病相比,新诊断糖尿病未增加短期健康状态恶化风险。

研究设计与样本

  • 研究纳入VIRGO研究中3501例18-55岁因急性心肌梗死住院且无已知糖尿病的患者。
  • 新诊断糖尿病定义为基线或1个月HbA1c≥6.5%、出院糖尿病诊断或1个月内启动糖尿病药物治疗。
  • 比较新诊断糖尿病、已诊断糖尿病和无糖尿病患者的基线特征及12个月内的健康状态、死亡率和院内并发症。

主要发现

  • 3501例患者中14.5%符合新诊断糖尿病标准。
  • 508例新诊断糖尿病患者中,35例(6.9%)获得出院诊断,91例(17.9%)接受出院糖尿病教育,14例(2.8%)在1个月内启动药物治疗。
  • 新诊断糖尿病与非白人(OR 1.58,95%CI 1.23-2.03)、肥胖(OR 1.72,95%CI 1.39-2.12)和经济压力(OR 1.27,95%CI 1.02-1.58)相关。
  • 与已诊断糖尿病相比,新诊断糖尿病独立关联更好的疾病特异性健康状况和生活质量(p≤0.04)。
  • 新诊断糖尿病与已诊断或无糖尿病相比,未调整的院内死亡率和并发症无显著差异。

临床怎么用

  • 对年轻急性心肌梗死患者应筛查新诊断糖尿病,尤其关注非白人、肥胖及经济压力大的人群。
  • 新诊断糖尿病患者出院时诊断和教育覆盖率低,需加强出院管理和早期干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine prevalence and characteristics of newly diagnosed diabetes (NDD) in younger adults hospitalised with acute myocardial infarction (AMI) and investigate whether NDD is associated with health status and clinical outcomes over 12-month post-AMI. METHODS: In individuals (18-55 years) admitted with AMI, without established diabetes, we defined NDD as (1) baseline or 1-month HbA1c≥6.5%; (2) discharge diabetes diagnosis or (3) diabetes medication initiation within 1 month. We compared baseline characteristics of NDD, established diabetes and no diabetes, and their associations with baseline, 1-month and 12-month health status (angina-specific and non-disease specific), mortality and in-hospital complications. RESULTS: Among 3501 patients in Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients study, 14.5% met NDD criteria. Among 508 patients with NDD, 35 (6.9%) received discharge diagnosis, 91 (17.9%) received discharge diabetes education and 14 (2.8%) initiated pharmacological treatment within 1 month. NDD was more common in non-White (OR 1.58, 95% CI 1.23 to 2.03), obese (OR 1.72, 95% CI 1.39 to 2.12), financially stressed patients (OR 1.27, 95% CI 1.02 to 1.58). Compared with established diabetes, NDD was independently associated with better disease-specific health status and quality of life (p≤0.04). No significant differences were found in unadjusted in-hospital mortality and complications between NDD and established or no diabetes. CONCLUSIONS: NDD was common among adults≤55 years admitted with AMI and was more frequent in non-White, obese, financially stressed individuals. Under 20% of patients with NDD received discharge diagnosis or initiated discharge diabetes education or pharmacological treatment within 1 month post-AMI. NDD was not associated with increased risk of worse short-term health status compared with risk noted for established diabetes. TRIAL REGISTRATION NUMBER: NCT00597922.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ding Q, Spatz ES, Lipska KJ, et al. Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults. Heart. 2020. PMID: 33082173. doi:10.1136/heartjnl-2020-317101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。